Marathon Capital Management Teva Pharmaceutical Industries LTD Transaction History

Marathon Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$7.9 - $10.19 $165,900 - $213,990	-21,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $24,750 - $28,900	-2,500 Reduced 10.64%	21,000 $207,000
Q4 2020 Feb 08, 2021	BUY	$8.61 - $11.04 $8,610 - $11,040	1,000 Added 4.44%	23,500 $226,000
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $28,066 - $41,559	-3,275 Reduced 12.71%	22,500 $202,000
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $209,292 - $338,168	25,775 New	25,775 $277,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Marathon Capital Management with notifications on news.